2016
DOI: 10.1016/j.ijcard.2015.12.031
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of contraceptive methods in women with congenital heart disease in Germany, Hungary and Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 16 publications
0
6
0
1
Order By: Relevance
“… 71) 76) 77) 78) Unfortunately, many women with CHD do not have adequate knowledge of safe contraception options. 76) 77) 78) 79) Estrogen-containing preparations are associated with thromboembolic risks and are contraindicated in women with cardiac conditions who are high-risk for thromboembolic complications. This includes women with mechanical valves, Eisenmenger syndrome and Fontan circulation.…”
Section: Contraceptionmentioning
confidence: 99%
“… 71) 76) 77) 78) Unfortunately, many women with CHD do not have adequate knowledge of safe contraception options. 76) 77) 78) 79) Estrogen-containing preparations are associated with thromboembolic risks and are contraindicated in women with cardiac conditions who are high-risk for thromboembolic complications. This includes women with mechanical valves, Eisenmenger syndrome and Fontan circulation.…”
Section: Contraceptionmentioning
confidence: 99%
“…These deficiencies have been also shown in other studies. [ 23 25 26 ] Given the high-risk pregnancy, especially unwanted pregnancies, in women with heart diseases, contraceptive method counseling is an important need of these women. [ 23 25 ] It is necessary to provide comprehensive reproductive health services to reduce the mortality and morbidity of these women.…”
Section: Discussionmentioning
confidence: 99%
“…Просечна старост прве упо требе контрацептивних средстава у овим земљама била је 18,4 године. (17,18) Истраживање ставова о употреби контра цепције међу женама у Шведској пружило је информације да 72,1% жена тренутно користи модерну контрацепцију. (19) У нашој студији укупна преваленција употребе контрацепције код жена (старости од 15 до 49 година) била је 34,8%.…”
Section: дискусијаunclassified